nitroglycerin has been researched along with wortmannin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ansenberger-Fricano, K; Bonini, MG; Fernandes, DC; Fukai, T; Laurindo, FR; Mao, M; Mason, RP; Minshall, RD; Stadler, K; Sudhahar, V; Tanaka, LY; Vasquez-Vivar, J | 1 |
1 other study(ies) available for nitroglycerin and wortmannin
| Article | Year |
|---|---|
Nitroglycerin drives endothelial nitric oxide synthase activation via the phosphatidylinositol 3-kinase/protein kinase B pathway.
Topics: Androstadienes; Animals; Aorta; Blood Pressure; Cattle; Cells, Cultured; Endothelial Cells; Enzyme Activation; Humans; In Vitro Techniques; Male; Mice; Microvessels; Nitric Oxide; Nitric Oxide Synthase Type III; Nitroglycerin; Phosphatidylinositol 3-Kinase; Phosphatidylinositol Phosphates; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Rats; Rats, Sprague-Dawley; Signal Transduction; Vasodilation; Vasodilator Agents; Wortmannin | 2012 |